GSE262596 EIF6 conditions drug-tolerant persister-like transdifferentiation in small cell lung carcinoma (eIF6_KD)
This study sheds light on eIF6's potential therapeutic interventions to mitigate treatment resistance in SCLC.
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by high throughput sequencing Homo sapiens Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Cancer Therapy | Carcinoma | Chemotherapy | Genetics | Men | Neurology | Small Cell Lung Cancer | Study